Related Experiment Videos

Caffeine pharmacokinetics in preterm infants older than 2 weeks

S A Pearlman1, C Duran, M A Wood

  • 1Department of Pediatrics, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey.

Developmental Pharmacology and Therapeutics
|January 1, 1989
PubMed

Insights

This study measured caffeine and theophylline metabolite levels in preterm infants. The average half-life for caffeine was approximately 52 hours, and for theophylline, it was about 77 hours.

Area of Science:

  • Neonatal Pharmacology
  • Pharmacokinetics
  • Clinical Chemistry

Background:

  • Preterm infants often require respiratory support.
  • Caffeine is commonly used to treat apnea of prematurity.
  • Understanding drug metabolism in neonates is crucial for safe and effective treatment.

Purpose of the Study:

  • To determine the plasma half-life of caffeine and its metabolite, theophylline, in preterm infants.
  • To provide pharmacokinetic data for caffeine in a neonatal population.

Main Methods:

  • Plasma levels of caffeine and theophylline were measured using high-pressure liquid chromatography.
  • Half-life was calculated via computer analysis employing the least-square method.
  • Study included 17 preterm infants with a mean gestational age of 29.7 weeks.

Main Results:

  • The mean caffeine half-life was 52.03 +/- 23.87 hours.
  • The mean theophylline half-life was 77.04 +/- 65.01 hours.
  • Infants were studied at a mean postnatal age of 20.7 days.

Conclusions:

  • Caffeine exhibits a prolonged half-life in preterm infants.
  • Theophylline, a major metabolite, also has an extended half-life in this population.
  • These findings are important for optimizing caffeine dosing strategies in neonates.

Related Concept Videos